| Title： | Expert Consensus on Interim Procurement of Novel Antineoplastic Drugs Based on Rapid Drug Evaluation in Yangtze River Delta |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Others |
| Countries and regions： | China |
| Guidelines users： | This consensus applies to medical institutions at all levels that carry out temporary procurement of antineoplastic drugs. |
| Evidence classification method： | Delphi method |
| Development unit： | Chinese Expert Consensus Panel on Interim Procurement of Novel Antineoplastic Drugs Based on Rapid Drug Evaluation in Yangtze River Delta |
| Registration time: | 2023-03-15 |
| Registration number： | PREPARE-2023CN166 |
| Purpose of the guideline: | In order to solve the problems in the process of temporary procurement of new antitumor drugs, this consensus is formulated to provide reference basis for the temporary procurement of new antitumor drugs for medical institutions at all levels. |
Latest registration
